Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatrice J Edwards

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 21, 2016
Incidence of Atypical Femur Fractures in Cancer Patients: The MD Anderson Cancer Center ExperienceBeatrice J Edwards, Ming Sun, Dennis P West, et al.
Breast Cancer Research and Treatment|April 19, 2017
Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expressionMonica E Reyes, Takeo Fujii, Daniel Branstetter, et al.
Journal of Oncology Practice|July 2, 2013
Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) projectBeatrice J Edwards, Sarah Usmani, Dennis W Raisch, et al.
Spine|November 27, 2019
Osteoporosis-related Vertebral Fragility Fractures: A Review and Analysis of the American Orthopaedic Association's Own the Bone DatabaseWilliam A Robinson, Bayard C Carlson, Heidi Poppendeck, et al.
Drug Safety|April 5, 2013
Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) projectJune M McKoy, Matthew J Fisher, D Mark Courtney, et al.
The Lancet. Oncology|November 29, 2008
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jawBeatrice J Edwards, Mrinal Gounder, June M McKoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2009
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylateDavid A Dorr, Rachel Burdon, Dennis P West, et al.
The Journal of Bone and Joint Surgery. American Volume|December 22, 2016
Own the Bone, a System-Based Intervention, Improves Osteoporosis Care After Fragility FracturesAndrew D Bunta, Beatrice J Edwards, William B Macaulay, et al.
Pediatric Radiology|September 24, 2013
Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR reportBeatrice Nardone, Elise Saddleton, Anne E Laumann, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 10, 2015
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral ResearchRobert A Adler, Ghada El-Hajj Fuleihan, Douglas C Bauer, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 21, 2016
Incidence of Atypical Femur Fractures in Cancer Patients: The MD Anderson Cancer Center ExperienceBeatrice J Edwards, Ming Sun, Dennis P West, et al.
Breast Cancer Research and Treatment|April 19, 2017
Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expressionMonica E Reyes, Takeo Fujii, Daniel Branstetter, et al.
Journal of Oncology Practice|July 2, 2013
Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) projectBeatrice J Edwards, Sarah Usmani, Dennis W Raisch, et al.
Spine|November 27, 2019
Osteoporosis-related Vertebral Fragility Fractures: A Review and Analysis of the American Orthopaedic Association's Own the Bone DatabaseWilliam A Robinson, Bayard C Carlson, Heidi Poppendeck, et al.
Drug Safety|April 5, 2013
Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) projectJune M McKoy, Matthew J Fisher, D Mark Courtney, et al.
The Lancet. Oncology|November 29, 2008
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jawBeatrice J Edwards, Mrinal Gounder, June M McKoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2009
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylateDavid A Dorr, Rachel Burdon, Dennis P West, et al.
The Journal of Bone and Joint Surgery. American Volume|December 22, 2016
Own the Bone, a System-Based Intervention, Improves Osteoporosis Care After Fragility FracturesAndrew D Bunta, Beatrice J Edwards, William B Macaulay, et al.
Pediatric Radiology|September 24, 2013
Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR reportBeatrice Nardone, Elise Saddleton, Anne E Laumann, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 10, 2015
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral ResearchRobert A Adler, Ghada El-Hajj Fuleihan, Douglas C Bauer, et al.
Pageof 6